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INTRODUCTION
Acute appendicitis (AA) is one of the most common paedi-
atric abdominal pathologies. It requires surgery, and despite
advances in diagnostics and treatment, a uniform under-
standing of the aetiology and pathogenesis of appendicitis is
still missing (Naher et al., 2013; Essenmacher et al., 2018;
Snyder et al., 2018). The physiology of the appendix has
also not been fully investigated. It is recognised that the ver-
miform appendix plays a role in the development and
maturation of the immune system (Gebbers and Laissue,
2004; Rhee et al., 2005). Involvement of microbes in the
pathogenesis of appendicitis is not entirely understood;
however, recent research suggests that the appendix func-
tions as a microbiota reservoir in the gastrointestinal tract.
The belief is that it ensures the repopulation of microbiota
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Treatment strategies for acute uncomplicated appendicitis have evolved and now conservative
antibacterial treatment is recommended over surgical treatment, especially for paediatric patients.
The aim of this study was to evaluate microbiota in paediatric patients with acute uncomplicated
and complicated appendicitis, and antibacterial susceptibility of the causative microorganisms.
Bacteriological identification was conducted using the VITEK2 analyser. Antibacterial susceptibil-
ity tests were performed and the results were evaluated in accordance with the recommendations
of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) “Clinical break-
points and dosing of antibiotics” (Version 7.0, January 2019). Serodiagnosis of Yersinia
enterocolitica was performed using indirect haemagglutination. The results revealed differences in
microbiota in cases of acute complicated and acute uncomplicated appendicitis. Pseudomonas
aeruginosa was identified more frequently in cases of acute complicated appendicitis. Mixed cul-
ture was prevalent in cases of both acute complicated and acute uncomplicated appendicitis.
Very few positive extended spectrum beta-lactamase (ESBL) Escherichia coli cultures were iden-
tified. Most of strains of Pseudomonas aeruginosa were resistant to amoxicillin with clavulanic
acid, ertapenem, ampicillin and cefotaxime. Some of E. coli isolates were resistant to ampicillin
and to amoxicillin with clavulanic acid.
Key words: appendicitis, microbiota, Pseudomonas aeruginosa, Escherichia coli, extended spec-
trum beta-lactamase, antibacterial susceptibility.
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during acute illnesses, in which the gastrointestinal tract is
colonised by pathogens such acute gastroenteritis, and after
antibacterial treatment (Guinane et al., 2013).
Historically, the only effective treatment method of appen-
dicitis and prevention of septic complications has been sur-
gery, namely, an appendectomy, which has been practiced
for over 130 years (Rogers et al., 2016). This view has been
challenged in recent years as conservative treatment using
antibiotics has supplanted surgical interventions (Lamps,
2010). Clinical research has demonstrated the efficacy of
antibacterial treatment, but nonetheless, 27% of patients
each year still require surgery (Roberts, 1988).
One of the most important issues in paediatric surgery is
distinguishing between acute uncomplicated appendicitis
(AnA) and acute complicated appendicitis (AcA) upon
commencing conservative treatment, as complicated cases
indicate a delay in establishing diagnosis and require emer-
gency surgery. These cases constitute more than 35% of all
AA cases in Latvia. Our current research showed that the
total number of AA cases treated surgically at the Chil-
dren’s Clinical University Hospital has not changed, but
there has been an increased incidence of AcA (Kakars et al.,
2017). Increase use of conservative treatment necessitates
the evaluation of algorithms for antibacterial treatment, as
they can differ among clinical institutions (Salo et al.,
2017).
The aim of this study was to evaluate microbiota in paediat-
ric patients with acute uncomplicated and complicated ap-
pendicitis, and antibacterial susceptibility of the causative
microorganisms.
MATERIALS AND METHODS
This study included children between the ages of seven and
17 admitted to the Children’s Clinical University Hospital
due to acute abdominal pain with signs and symptoms sug-
gesting the possibility of appendicitis. All patients were ex-
amined to confirm or exclude this diagnosis. Preoperative
screening involved physical examination, complete blood
count, abdominal ultrasound (US) and detection of serum
values of C-reactive protein (CRP) and interleukin-6 (IL-6).
The paediatric surgery team supervising patients with ap-
pendicitis received a written consent form from the care-
giver and assent from the patient if they were 13 years of
age or older. The consent form provided information to the
patient and the caregiver about the research objective and
methodology used for examining the biological material.
Ethical approval: All procedures performed in this study in-
volving human participants were in accordance with the
ethical standards of the institutional and/or national research
committee (Rîga Stradiòð University; reference number:
21/27.04.2017; and Children’s Clinical University Hospital;
reference number: SP-37/2018), and with the 1964 Helsinki
declaration and its later amendments or comparable ethical
standards. Informed consent was obtained from a parent of
each individual participant included in the study. Clinical
data collected prior to surgery included patients’ age, sex,
and current medical history.
Altogether, a total of 67 patients were eligible and recruited
for this study. All of these patients had an appendectomy,
and either laparoscopic or conventional laparotomy was
performed in all of the patients. Intraoperatively, a micro-
biological culture swab from the peritoneal cavity was col-
lected. After the removal of the appendix, an extra submu-
cosal swab was taken to avoid bacterial dissemination from
the following swabs. The appendix was dissected longitudi-
nally and under sterile conditions, and swab samples were
taken from the distal and proximal part of the appendiceal
lumen. Each pair was placed in Amies medium for immedi-
ate transfer and subsequent bacterial culture (Schulin et al.,
2017). They were cultivated under aerobic and anaerobic
conditions. Cultivation was performed on blood agar (Sup-
plement, Oxid, UK; defibrinated sheep blood – E&O labo-
ratories limited, Scotland), MacConkey (Oxid, UK) and
tripticase soy (Oxid, UK) agar. Bacterial identification was
performed using the VITEK2 analyser (Biomerieux,
France).
Antibacterial susceptibility tests were performed and the re-
sults were evaluated in accordance with the recommenda-
tions of the European Committee on Antimicrobial Suscep-
tibility Testing (EUCAST), “Clinical breakpoints and
dosing of antibiotics” (Version 7.0, January 2019) (Anony-
mous, 2019). Overnight cultures were suspended in physio-
logical saline to 0.5 McFarland units (McFarland Densi-
tometer DEN-1, Biosan, Latvia). The suspension was
inoculated on Mueller-Hinton agar (Oxid, UK). Selected an-
tibiotics were placed on the inoculated plates and included
ceftazidime 10 µg, ampicillin 10 µg, cefotaxime 5 µg, mero-
penem 10 µg, imipenem 10 µg, amikacin 30 µg, gentamicin
10 µg, ciprofloxacin 5 µg, chloramphenicol 30 µg, ertape-
nem 10 µg, amoxicillin+clavulanic acid 30 µg, and piper-
acillin+tazobactam 36 µg (Liofilchem, Italy). The plates
were incubated at +35 ± 1°C temperature for 18 ± 2 h. A
double disk synergy test (DDST) was used to confirm ex-
tended spectrum beta-lactamase (ESBL). Disks containing
cephalosporins (cefotaxime, ceftazidime) were applied to
plates next to a disk with clavulanic acid (amoxicillin-
clavulanic acid). A positive result was indicated if the inhi-
bition zones around any of the cephalosporin disks were
augmented in the direction of the disk containing clavulanic
acid. Results were evaluated by measuring the zone of inhi-
bition, and resistance was interpreted in accordance with the
EUCAST breakpoints.
Haematoxylin-eosin staining was performed and the grade
of inflammation was assessed, differentiating gangrenous
and phlegmonous appendicitis. Serodiagnosis of Yersinia
enterocolitica was performed using indirect (passive) hae-
magglutination.
For statistical analysis, Microsoft Excel 2016 and IBM
SPSS Statistics 22 were employed. Results were expressed
as median values and interquartile ranges (IQR). The com-
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parison between groups was made using both the Mann–
Whitney U-Test (two groups) and Kruskal–Wallis test
(three groups) for non-parametric distribution, and the
Fisher Exact Test was applied on normally distributed vari-
ables to determine correlations between them. A p-value of
< 0.05 was considered statistically significant. The data was
entered in SPSS and validated by an additional statistical
analyst for accuracy.
RESULTS
A total of 67 children having arrived at the Emergency De-
partment were included in this study (33 males, 34 females).
Patient age ranged 7–17 years with a median age of 12
years. Depending on the intraoperative and bacteriological
findings, two patient groups were established (Table 1). Pa-
tients with positive culture from samples of the peritoneal
cavity were classified in the AcA group, which consisted of
34 patients (50.7%). Those patients with a negative culture
were classified in the AnA group, which consisted of 33 pa-
tients (49.3%). There was no statistically significant differ-
ence between the results of the samples taken from the ana-
tomical parts of the appendiceal lumen. E. coli was the
prevalent representative of appendiceal intraluminal micro-
biota in both complicated and uncomplicated cases, total-
ling 51 patients (76.0%). P. aeruginosa was the prevalent
microorganism of the extraluminal appendiceal microbiota
(AcA/AuA:13/1). There were some differences in microbi-
ota of the proximal and distal parts of the appendix between
patients with acute complicated and acute uncomplicated
appendicitis. In 22 of 34 AcA cases (55.0%) microbiota
were identical, but the microbiota in distal and proximal
parts differed for the remaining 12 cases (35.0%).
Bacteria were grown from samples of submucosa in both
acute complicated and uncomplicated appendicitis. E. coli
was the prevalent species, with P. aeruginosa being the sec-
ond most commonly isolated microorganism (Table 1). His-
tological examination of surgically removed specimens
showed a significant correlation between gangrenous ap-
pendicitis in AcA and phlegmonous appendicitis in AnA
(Chi-square = 15.246, df = 1, p < 0.001). More than a half
of the patients (61.3%) who had a drainage tube inserted
were diagnosed with AcA (p = 0.004). A simple compari-
son suggested that AnA had a slightly shorter median post-
operative hospital stay of five versus six days. Yersinia en-
terocolitica antibody detection preoperatively was negative
in all cases. The remaining demographics and clinical char-
acteristics of the patients are shown in Table 2.
Bacterial culture resulted in positive intraluminal samples
with growth of one or several strains from each appendix.
Table 2 shows the number of cases of the most common
isolates for the AcA and AnA patient groups. Frequently,
mixed strains were found at culture. The most common bac-
teria isolated from the appendix were Escherichia coli in 46
(37.4%), followed by Pseudomonas aeruginosa in 16
(13.0%), Klebsiella pneumoniae in nine (7.3%), Bacterioi-
des fragilis in six (4.9%), and Citrobacter braakii in four
samples (3.3%) (Table 2, Fig. 1). The 46 samples isolating
E. coli had various antibacterial sensitivities: four (~8.7%)
strains were resistant to ceftazidime; 17 (~37%) to ampicil-
lin; three (~6.5%) to cefotaxime; one (~2.17%) to imipe-
nem; four (~8.7%) to ciprofloxacin; three (~6.5%) to chlo-
ramphenicol; two (~4.34%) to ertapenem; nine (~19.5%) to
102 Proc. Latvian Acad. Sci., Section B, Vol. 74 (2020), No. 2.
Table 1. Types of isolated bacteria, frequency and percentage in acute




No. % No. %
Escherichia coli 24 47.1 27 52.9 51 0.460#
Pseudomonas
aeruginosa
13 92.9 1 7.1 14 0.098*
Klebsiella pneumoniae 3 50.0 3 50.0 6 0.480
Citrobacter braakii 0 0 3 100.0 4 0.053*
Bacterioides fragilis 1 20.0 4 80.0 5 0.321
Mixed cases 23 51.1 22 48.9 45 0.867
Total 60 63 123
AcA, acute complicated appendicitis; AnA, acute uncomplicated appendi-
citis, # Pearson Chi-square test, * Fisher Exact test
Table 2. Characteristics and distribution of the study population
AcA AnA Total p-value
Children, n (%) 34 (50.7) 33 (49.3) 67 0.288
Age, median (IQR) 12 (9–15) 11 (10–15) – 0.200
Laboratory values
WBC count (×109/l), 16.7 14.5 – < 0.001
CRP (g/l), 27.6 10.3 – 0.050
Duration of symptoms, h (IQR) 28 (16–51) 20 (12–26) – 0.038
Alvarado score, points 8 7 – < 0.001
Type of surgery, n (%)
0.349
Laparotomy 7 (63.6) 4 (36.4) 11
Laparoscopy 26 (48.1) 28 (51.9) 54
Histology, n (%)
Phlegmonous 10 (29.4) 24 (70.6) 34 < 0.001
Gangrenous 23 (74.2) 8 (25.8) 31
Drainage tube, n (%) 19 (70.4) 8 (29.6) 27 0.008
Length of hospital stay, days
(IQR)
6 (5–9) 5 (4–6) – 0.006
AcA, acute complicated appendicitis; AnA, acute uncomplicated appendi-
citis; IQR, interquartile range; WBC, white blood cells; CRP, C-reactive
protein. Median values are presented with IQR (25%, 75%)
Fig 1. Types of organisms isolated.
amoxicillin/clavulanic acid, and two (~4.34%) to piperacil-
lin-tazobactam. All strains were susceptible to meropenem,
amikacin and gentamicin. Additionally, two ESBL-pro-
ducing strains of E. coli were also isolated.
P. aeruginosa was isolated from 15 samples. Antibacterial
resistance was shown for four (26.7%) strains to cef-
tazidime; 11 (73.3%) to ampicillin; eight (53.3%) to cefo-
taxime; five (33.3%) to imipenem; five (33.3%) to chloram-
phenicol; 11 (73.3%) to ertapenem; 11 (73.3%) to
amoxicillin/clavulanic acid and one (6.67%) to piperacil-
lin-tazobactam. All strains were susceptible to meropenem,
amikacin, gentamicin and ciprofloxacin. Other bacteria
from the Enterobacteriaceae family were also isolated, such
as Citrobacter spp., Klebsiella spp., and others. Citrobacter
spp. were resistant to amoxicillin/clavulanic acid, and Kleb-
siella spp. were resistant to ampicillin.
DISCUSSION
Research has shown that appendiceal luminal obstruction,
by creating a closed loop, is the cause of appendicitis. Lym-
phoid hyperplasia in the follicles of the submucosa is the
typical cause of luminal obstruction in children. Faecolith is
mentioned as a precipitating obstructive factor (Bhangu et
al., 2015), while parasites (e.g. nematodes) and inflamma-
tory constrictions are less common causes. Obstruction
leads to increased bacterial proliferation, thus increasing the
intraluminal pressure that subsequently impedes blood flow,
which results in congestion and ischemia that promotes bac-
terial colonisation.
Although obstruction is the leading theory behind patho-
genesis of appendicitis, it is not fully consistent with the
data obtained in research and clinical practice. Therefore,
bacteria are believed to also play a role in the pathogenesis.
There is also a hypothesis highlighting the importance of
genetic predisposition as the prevalence of appendicitis is
higher among first-degree relatives. Finally, perforated and
non-perforated appendicitis, which represent disease pro-
gression from an early to a late stage, are epidemiologically
recognised as two distinct processes (Bhangu et al., 2015;
Abdussemee et al., 2018; Essenmacher et al., 2018). There
is a dispute regarding whether the most common causative
agents are E. coli and anaerobic Clostridium perfringens
(Abdussemee et al., 2018), as opposed to Klebsiella spp.
and Enterobacter spp. (Parthiban and Harish 2017), or
Bacteroides fragilis, Pseudomonas aeruginosa and Pepto-
streptococcus spp. (Roberts, 1988; Lamps, 2010; Guillet-
Caruba et al., 2011; Chen et al., 2012).
The results of our study demonstrated that 53.0% of P. ae-
ruginosa isolates were resistant to cefotaxime, and about a
third against ceftazidime. Cefotaxime is included in the
guidelines of the Children’s Clinical University Hospital for
treatment of intraperitoneal infections in paediatric patients
(Anonymous, 2013). Although both antibiotics belong to
third generation cephalosporins, ceftazidime has shown
more efficacy in the treatment of infections with gram nega-
tive bacteria, especially Pseudomonas spp., an important
causative agent of nosocomial infections (Anonymous,
2019). Treatment typically involves the use of beta-lactam
antibiotics; however, ceftazidime is the most important anti-
bacterial agent, which functions as a cell wall synthesis in-
hibitor by binding to penicillin-binding protein 3 (PBP3)
(Koss et al., 2016). Nevertheless, ceftazidime-resistant
strains have been discovered. Resistance mechanisms
against ceftazidime in P. aeruginosa include the production
of beta-lactamase encoded by genes acquired via horizontal
gene transfer, or by increased production of a drug-induced,
broad-spectrum, chromosomally encoded class C beta lacta-
mase with an altered affinity (Fisher and Mobashery, 2014).
The frequency of resistance against ceftazidime in isolates
can fluctuate between 35% to 86% (Du et al., 2010; Noha et
al., 2015).
In our study, P. aeruginosa was prevalent in samples ob-
tained from patients with acute complicated appendicitis.
All strains were sensitive to meropenem, which inhibits cell
wall synthesis and is not affected by beta-lactamase (Bald-
win et al., 2008). Drusano et al. (2018) investigated the po-
tential use of fosfomycin in the treatment of infections with
P. aeruginosa and discovered that the bacteria rapidly de-
veloped resistance against fosfomycin. Therefore, they sug-
gested switching treatment from monotherapy to combina-
tion therapy with fosfomycin and meropenem. A synergistic
effect was observed with fosfomycin eradicating the
meropenem-resistant mutants and meropenem working
against fosfomycin-resistant strains. Thus, this combination
was recommended as a treatment strategy for wider use in
the future (Drusano et al., 2018). Another combination dis-
playing promising results in research settings is meropenem
in conjunction with ceftazidime (Feng et al., 2017). In the
past decade, the following antibiotic combinations have
been investigated as potential treatment options (Gracia et
al. 2018).
Ceftazidime-Avibactam. Avibactam is a member of the
class of azabicycloalkanes. Avibactam is a non-beta-lactam
beta-lactamase inhibitor that is available in combination
with ceftazidime (Avycaz). This combination was approved
by the Food and Drug Administration (FDA) on 25 Febru-
ary 2015 for the treatment of complicated intra-abdominal
infections in combination with metronidazole (Anonymous,
2019). This combination has shown efficacy of up to 90%
against ceftazidime-resistant strains of P. aeruginosa
(Mazuski et al., 2016; Qin et al., 2017). Combined treat-
ment with ceftazidime-avibactam and colistin has shown
promise in treating infections with XDR (extremely
drug-resistant) P. aeruginosa (Xipell et al, 2017).
Ceftolozane-Tazobactam. Ceftolozane-tazobactam was
approved by the FDA in 2014, shortly before ceftazidime-
avibactam was approved for the same indications. It is
highly effective in combinations with meropenem and levo-
floxacin (Solomkin et al., 2015; Wagenlehner et al., 2015;
Gracia et al., 2018).
In our study, amikacin demonstrated significant efficacy
against isolates from samples. It is a broad-spectrum semi-
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synthetic aminoglycoside antibiotic, derived from kanamy-
cin with antimicrobial properties. Amikacin irreversibly
binds to the bacterial 30S ribosomal subunit, specifically
locking 16S rRNA and S12 protein within the 30S subunit.
This leads to interference with the translational initiation
complex and misreading of mRNA, thereby hampering pro-
tein synthesis and resulting in the bactericidal effect. This
agent is usually used in short-term treatment of serious in-
fections due to susceptible strains of Gram-negative bacteria
(Anonymous, 2019). Data is scarce regarding amikacin-re-
sistant pseudomonas. Research conducted by Loho et al.
(2018) showed that only two of 20 P. aeruginosa isolates
were resistant against amikacin. Its combination with
doripenem is synergistic and improves treatment results.
The most commonly isolated microorganism from our pa-
tients’ samples was E. coli, especially from those treated for
acute uncomplicated appendicitis. This finding concurs with
results obtained by other authors (Naher et al., 2013;
Bhangu et al., 2015; Abdussemee et al., 2018; Bazzaz et al.,
2018; Essenmacher et al., 2018; Rickard et al., 2018;
Snyder et al., 2018; Turel et al., 2018). Our data revealed
that strains of E. coli are sensitive to antibacterial agents
such as amikacin, imipenem, and meropenem, which is in
line with recent studies by other researchers (Bazzaz et al.,
2018). There were strains resistant against other antibacte-
rial agents included in the treatment guidelines; three and
four of 47 were resistant to cefotaxime and ceftazidime, re-
spectively. Only two isolates were ESBL-positive. This
complies with data from other studies that showed the prev-
alence of ESBL-producing E. coli in Latvia. 11% of E. coli
present in animal microbiota produce ESBL (Terentjeva et
al., 2019), whereas in the adult population, ESBL are pro-
duced by only 1.6% of E. coli (Ny et al., 2018).
CONCLUSIONS
In cases of acute complicated appendicitis, P. aeruginosa is
the prevalent microorganism, whereas E. coli is the most
commonly isolated microorganism in acute uncomplicated
appendicitis. Antibiotic treatment strategies in cases of
acute complicated appendicitis should include antibiotics
with different mechanisms of action to achieve a synergistic
effect and prevent the development of antibiotic resistance.
Mixed culture results were prevalent in both acute compli-
cated and acute uncomplicated appendicitis. The incidence
of ESBL producing microorganisms was low in these acute
appendicitis cases.
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MIKROBIOTAS BAKTERIOLOÌISKA IZVÇRTÇÐANA BÇRNIEM AKÛTA APENDICÎTA GADÎJUMÂ
Pçdçjo gadu laikâ ir mainîjusies akûta nekomplicçta apendicîta ârstçðanas taktika, kuras ietvaros rekomendçta antibakteriâlâ terapija nevis
íirurìiska operâcija, îpaði bçrniem. Ðî pçtîjuma mçríis bija izvçrtçt mikrobiotu pediatriska vecuma pacientiem ar akûtu komplicçtu un
nekomplicçtu apendicîtu, kâ arî izvçrtçt etioloìisko ierosinâtâju antibakteriâlo jutîbu. Darbâ tika izmantotas bakterioloìiskâs metodes,
mikroorganismu identifikâcija veikta, izmantojot VITEK2 analizatoru. Antibakteriâlâs jutîbas testi tika veikti un rezultâti izvçrtçti saskaòâ
ar Eiropas antimikrobiâlâs jutîbas testçðanas (EUCAST, Versija Nr. 7.0, 2019. g. janvâris) rekomendâcijâm. Yersinia enterocolitica
serodiagnostikâ tika izmantota netieðâ hemaglutinâcijas redakcija. Pçtîjuma rezultâti liecina, ka ir microbiota atðíirîbas akûta komplicçta un
nekomplicçta apendicîta gadîjumâ. Akûta komplicçta apendicîta gadîjumâ prevalçja Pseudomonas aeruginosa. Akûtu apendicîtu gadîjumâ
pârsvarâ izdalîtas mikroorganismu asociâcijas. No pçtîjumâ iekïautajiem pacientiem tikai atseviðíos gadîjumos tika izdalîti ESBL
producçtâji. Daïa Pseudomonas aeruginosa celmu bija rezistenti pret amoksicilînu ar klavulânskâbi, ertapençmu, ampicilînu un
cefotaksîmu. Daïa izdalîto E. coli celmu bija rezistenti pret ampicilînu un amoksicilînu ar klavulânskâbi.
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